A detailed history of Freemont Management S.A. transactions in Dexcom Inc stock. As of the latest transaction made, Freemont Management S.A. holds 76,300 shares of DXCM stock, worth $8.47 Million. This represents 1.64% of its overall portfolio holdings.

Number of Shares
76,300
Previous 100,000 23.7%
Holding current value
$8.47 Million
Previous $12.4 Million 14.72%
% of portfolio
1.64%
Previous 1.67%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$114.22 - $140.1 $2.71 Million - $3.32 Million
-23,700 Reduced 23.7%
76,300 $10.6 Million
Q4 2023

Feb 09, 2024

SELL
$75.49 - $124.16 $9.38 Million - $15.4 Million
-124,200 Reduced 55.4%
100,000 $12.4 Million
Q3 2023

Nov 09, 2023

BUY
$86.06 - $137.93 $8.02 Million - $12.9 Million
93,200 Added 71.15%
224,200 $20.9 Million
Q4 2022

Feb 10, 2023

BUY
$84.98 - $122.67 $11.1 Million - $16.1 Million
131,000 New
131,000 $14.8 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $42.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Freemont Management S.A. Portfolio

Follow Freemont Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freemont Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Freemont Management S.A. with notifications on news.